abstract gray background

Archives: Resources

PPD | White Paper
Capital efficiency in cardiovascular outcomes trials

Explore the white paper to learn how integrated CVOT execution can accelerate timelines, manage MACE accrual and improve program value in Phase III trials.

Get the white paper
PPD | Webinar
Transforming HEOR with AI and Real-World Data

Explore how AI and real-world data can strengthen HEOR, evidence generation and health economic modeling across the therapy lifecycle.

Read More
PPD | Case Study
Accelerated GMP lab support for gene therapy program

Learn how flexible GMP analytical testing helped accelerate gene therapy dose release while supporting faster decisions and quality delivery for patients.

Read More
PPD | e-book
Modernize chronic disease trials through digital transformation

Wearables, remote monitoring and decentralized trial models can reduce patient burden, support engagement and capture meaningful data in chronic disease trials.

View the e-book
PPD | Report
Meeting Pregnancy and Lactation Safety Requirements: A Guide for Sponsors

Build a more efficient, compliant, and patient-centered approach to pregnancy and lactation safety studies with expert-backed strategies in this practical guide.

Read the report
PPD | Overview
Optimizing your oncology endpoint data collection

Explore key considerations for improving oncology endpoint data collection across imaging, eCOA, connected devices and cardiac safety.

Read the overview
PPD | Case Study
Moving beyond paper: eCOA successfully delivered across three Phase I oncology studies

Discover how at-home eCOA supported participant compliance, data quality and early oncology trial insights across three Phase I studies.

Read More
PPD | Overview
Regulatory guidance for PRO strategy in oncology trials

Explore regulatory considerations for incorporating patient-reported outcomes into oncology trials to support patient-centered evidence.

Read the overview
PPD | Case Study
Standardized imaging and ECG data in Alzheimer’s trials

Discover how standardized MRI, PET and ECG data collection supported evidence generation in a complex global Alzheimer’s disease study.

Read More